Aberdare Ventures
Aberdare Ventures offers the healthcare industry with seed, early, and later stage venture, private equity, and grants investments.
Business Model:
Revenue: $17.6M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Aberdare Ventures Information
Geographic Data
Address: 235 Montgomery St
City: San Francisco
State: CA
Zip: 94104
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.
Contact Phone:
+14153927442
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 3/2005 | Sequoia Pharmaceuticals | Series B | 22M |
| 12/2010 | Jiff | Seed Round | 1M |
| 6/2002 | Salmedix | Series B | 27.5M |
| 11/2002 | Anacor Pharmaceutical | Venture Round | 4M |
| 6/2008 | VertiFlex | Series C | 28.3M |
| 1/2007 | VertiFlex | Series B | 20M |
| 9/2014 | Jiff | Series B | 0 |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 11/2000 | Microbia | Series B | 0 |
| 11/2012 | Wello | Seed Round | 1M |
| 9/2013 | Adavium | Private Equity Round | 20M |
| 5/2005 | Anacor Pharmaceutical | Series C | 25M |
| 7/2017 | Gravie | Series C | 0 |
| 6/2015 | Realeve | Series D | 43.2M |
| 4/2010 | Viracta Therapeutics | Series B | 12M |
| 8/2006 | Kemia | Series C | 0 |
| 2/2011 | VertiFlex | Venture Round | 14M |
| 3/2012 | Viracta Therapeutics | Series B | 0 |
| 3/2014 | goBalto | Venture Round | 0 |
| 5/2015 | Jiff | Series C | 0 |
| 6/2007 | Paracor Medical | Series D | 44M |
| 10/2011 | Realeve | Series C | 32M |
| 3/2011 | Posit Science | Venture Round | 3.1M |
| 2/2011 | Conatus Pharmaceuticals | Series B | 0 |
| 9/2010 | EnteroMedics | Post-IPO Equity | 6.3M |
| 1/2015 | goBalto | Series C | 0 |
| 5/2006 | Eledon Pharmaceuticals | Series B | 35M |
| 3/2012 | Jiff | Series A | 7.5M |
| 4/2015 | Gravie | Series B | 0 |
| 12/2008 | Aviir | Venture Round | 7.8M |
| 9/2012 | RxAnte | Series A | 4.6M |
| 10/2009 | Aviir | Venture Round | 1M |
| 9/2007 | Aviir | Series B | 11.3M |
| 6/2013 | Aviir | Series B | 10M |
| 1/2010 | Aviir | Venture Round | 4.2M |
| 1/2009 | Anacor Pharmaceutical | Series E | 0 |
| 12/2011 | Aviir | Venture Round | 10M |
| 3/2008 | Aviir | Venture Round | 1.5M |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 7/2005 | VertiFlex | Series A | 6.3M |
| 12/2006 | NBI Development | Seed Round | 5.5M |
| 9/2018 | Cricket Health | Series A | 0 |
| 9/2013 | Advance Medical | Series B | 20M |
| 1/2007 | Sequoia Pharmaceuticals | Series C | 35M |
| 10/2011 | NxThera | Series B | 0 |
| 4/2000 | Alibris | Series D | 30M |
| 7/2002 | Anacor Pharmaceutical | Series A | 2.9M |
| 2/2009 | Mpex Pharmaceuticals | Series D | 27.5M |
| 12/2001 | Pharmion | Venture Round | 65M |
| 6/2004 | Idun Pharmaceuticals | Venture Round | 0 |
| 12/2006 | Nevro | Seed Round | 5.5M |
| 9/2008 | Nevro | Series A | 21.8M |
| 7/2011 | Nevro | Series B | 58M |
| 5/2009 | Clovis Oncology | Venture Round | 145M |
| 8/2018 | MC10 | Venture Round | 0 |
| 1/2011 | Rock Health | Grant | 0 |
| 12/2011 | Omada Health | Seed Round | 800k |
| 5/2007 | Conatus Pharmaceuticals | Series A | 22M |
| 8/2005 | Mpex Pharmaceuticals | Series B | 0 |
| 5/2015 | Realeve | Series D | 38M |
| 2/2013 | Aviir | Series B | 10M |
| 10/2012 | Bluesight | Seed Round | 100k |
| 9/2008 | Cervel Neurotech | Series A | 1.5M |
| 12/2012 | MC10 | Series C | 10M |
| 1/2012 | MC10 | Venture Round | 2M |
| 7/2007 | Ablation Frontiers | Series C | 0 |
| 12/2012 | goBalto | Series B | 0 |
| 12/2006 | Posit Science | Series B | 14.5M |
| 4/2009 | Posit Science | Venture Round | 5.6M |
| 6/2011 | Aviir | Venture Round | 3M |
| 3/2014 | Gravie | Series A | 0 |
| 9/1999 | CapitalThinking | Series A | 3.4M |
| 4/2013 | Cervel Neurotech | Venture Round | 14.1M |
| 9/2018 | Cricket Health | Series A | 0 |
| 8/2018 | MC10 | Venture Round | 0 |
| 7/2017 | Gravie | Series C | 0 |
| 6/2015 | Realeve | Series D | 0 |
| 5/2015 | Jiff | Series C | 0 |
| 5/2015 | Realeve | Series D | 0 |
| 4/2015 | Gravie | Series B | 0 |
| 1/2015 | goBalto | Series C | 0 |
| 9/2014 | Jiff | Series B | 0 |
| 3/2014 | Gravie | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
